The New York Times reports that yesterday, at a federal court in Boston, founder of opioid drug maker Insys Therapeutics, John Kapoor and four of his top executives, were guilty of racketeering. Not only had they bribed doctors to prescribe their very strong and highly addictive nasal spray Subsys, but had misled health insurers about patents’ need for the medication. This marks another step in the fight against an opioid crisis in the US which has killed 200,000 people over the last two decades.
To continue reading, register today
to enjoy limited access to the following:
- Daily trading news
- Funds coverage
- Features on big investment themes
- Comprehensive companies coverage
- Economic analysis